It's time to bring dendritic cell therapy to type 1 diabetes
Diabetes
.
2014 Jan;63(1):20-30.
doi: 10.2337/db13-0886.
Authors
Rémi J Creusot
1
,
Nick Giannoukakis
,
Massimo Trucco
,
Michael J Clare-Salzler
,
C Garrison Fathman
Affiliation
1
Department of Medicine, Columbia Center for Translational Immunology and Naomi Berrie Diabetes Center, Columbia University Medical Center, New York, NY.
PMID:
24357690
PMCID:
PMC3968436
DOI:
10.2337/db13-0886
No abstract available
Publication types
Research Support, N.I.H., Extramural
Review
MeSH terms
Cell Transplantation
Dendritic Cells / transplantation*
Diabetes Mellitus, Type 1 / therapy*
Humans
Grants and funding
R33 DK063499/DK/NIDDK NIH HHS/United States
P01 AI042288/AI/NIAID NIH HHS/United States
U19 AI070352/AI/NIAID NIH HHS/United States
UO1 DK078123/DK/NIDDK NIH HHS/United States
U01 DK078123/DK/NIDDK NIH HHS/United States
R33 DK063422/DK/NIDDK NIH HHS/United States